ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,756, issued on Aug. 25.
"Isolated modified AAV9 capsid protein VP1" was invented by Anna Nikolaevna Strelkova (Yaransk, Russia), Tatiana Evgenievna Shugaeva (Moscow), Pavel Mikhailovich Gershovich (Saint Petersburg, Russia), Pavel Andreevich Iakovlev (Saint Petersburg, Russia) and Dmitry Valentinovich Morozov (Saint-Petersburg, Russia).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to the fields of gene therapy and molecular biology. More specifically, the present invention relates to an isolated modified capsid protein VP1 from adeno-associated virus serotype 9 (AAV9) comprising one or more amino acid substitutions co...